by Jordana Choucair | Jan 27, 2023 | Life Sciences
A Food and Drug Administration (FDA) expert panel voted unanimously on a proposal to simplify the nation’s strategy for vaccinating people against COVID-19. Currently, unvaccinated individuals still receive monovalent vaccines based on the original COVID-19...
by Jordana Choucair | Jan 26, 2023 | Life Sciences
New research from the Centers for Disease Control and Prevention (CDC) found that updated COVID-19 boosters are cutting the risk that a person will get sick from the coronavirus by about half. For adults between the ages 18 and 49, the studies showed COVID-19 boosters...
by Jordana Choucair | Jan 26, 2023 | Life Sciences
Frank Yiannas, Food and Drug Administration (FDA) deputy commissioner for the Office of Food Policy and Response, is resigning less than two months after a report criticized the structure and culture of the FDA’s food program and recommended a major overhaul....
by Jordana Choucair | Jan 24, 2023 | Life Sciences
New documents show that the Food and Drug Administration (FDA) wants to make Covid-19 vaccination a regular, once-a-year shot that is updated to match current strains of the virus. The agency would recommend two annual boosters of the revised shot for people who are...
by Jordana Choucair | Jan 24, 2023 | Life Sciences
Amazon.com Inc announced it will offer a $5 monthly subscription plan for U.S. Prime members that will cover a range of generic drugs and their doorstep delivery. The RxPass program includes more than 50 generic medications addressing over 80 chronic conditions. The...
by Jordana Choucair | Jan 24, 2023 | Life Sciences
Optum Rx launched Price Edge – a new tool that aims to make it easier to compare the direct-to-consumer price for generic drugs to the price with insurance. The tool, which is available at no additional cost to all of its pharmacy benefit manager (PBM) clients, scans...
Recent Comments